APTARGROUP, INC.

ATR 10-K · FY 2025
API behind this page

ATR FY 2025 request

Playground key active
Request URL /api/financials?ticker=ATR&year=2025&quarter=4&full_year_mode=true
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric FY 2025 FY 2024 YoY
Revenue 3,777,181 3,582,890 +5.4%
Show Business Segments breakouts
Beauty 1,309,437 1,225,730 +6.8%
Beauty · Intersegment Elimination -28,701 -27,174 -5.6%
Beauty · Operating Segments 1,338,138 1,252,904 +6.8%
Closures 730,263 714,008 +2.3%
Closures · Intersegment Elimination -6,680 -7,556 +11.6%
Closures · Operating Segments 736,943 721,564 +2.1%
Pharma 1,737,481 1,643,152 +5.7%
Pharma · Intersegment Elimination -989 -860 -15.0%
Pharma · Operating Segments 1,738,470 1,644,012 +5.7%
Show Consolidation Items breakouts
Intersegment Elimination -36,370 -35,590 -2.2%
Operating Segments 3,813,551 3,618,480 +5.4%
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization 2,372,446 2,227,381 +6.5%
Show Business Segments breakouts
Beauty · Operating Segments 965,316 884,433 +9.1%
Closures · Operating Segments 523,939 511,409 +2.5%
Pharma · Operating Segments 885,928 834,595 +6.2%
Selling Research And Development And Administrative Expenses 606,497 582,226 +4.2%
Show Business Segments breakouts
Beauty · Operating Segments 194,246 183,903 +5.6%
Closures · Operating Segments 91,921 89,913 +2.2%
Pharma · Operating Segments 252,946 241,357 +4.8%
Cost Of Goods And Services Sold Depreciation And Amortization 287,363 263,784 +8.9%
Restructuring Charges 9,837 13,002 -24.3%
Show Business Segments breakouts
Beauty · Operating Segments 4,469 8,041 -44.4%
Closures · Operating Segments 3,566 3,835 -7.0%
Pharma · Operating Segments 1,080 589 +83.4%
Show Consolidation Items breakouts
Corporate & Other 722 537 +34.5%
Show Restructuring Cost And Reserve breakouts
Employee Severance · Business Optimization Plan 2,350 6,562 -64.2%
Optimization initiative 9,837 13,019 -24.4%
Professional fees and other costs · Business Optimization Plan 7,487 6,457 +16.0%
Show Restructuring Plan breakouts
Business Optimization Plan 9,837 13,019 -24.4%
Optimization Plan 9.8 13 -24.6%
Total Costs & Expenses 3,276,143 3,086,393 +6.1%
Operating Income 501,038 496,497 +0.9%
Interest Expense -52,737 -43,898 -20.1%
Interest Income 11,676 12,101 -3.5%
Gain Loss On Investments -483 1,713 -128.2%
Show Financial Instrument breakouts
Preferred Stock · PureCycle -483 1,713 -128.2%
Income Loss From Equity Method Investments 7,393 87 +8397.7%
Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain 26,518 — —
Other Non-Operating Income (Expense) -2,027 3,265 -162.1%
Show Derivative Risk breakouts
Currency Swap · Cash Flow Hedging -2,027 — —
Nonoperating Income Expense Including Income Loss From Equity Method Investments -9,660 -26,732 +63.9%
Income Before Taxes 491,378 469,765 +4.6%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment Net Prior Service Cost Credit · Reclassification Out Of Accumulated Other Comprehensive Income -101 -349 +71.1%
Accumulated Defined Benefit Plans Adjustment Net Unamortized Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income -760 -201 -278.1%
Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income -861 -550 -56.5%
Income Tax Expense (Benefit) 98,881 95,587 +3.4%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income -265 -180 -47.2%
Net Income 392,497 374,178 +4.9%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income -596 -370 -61.1%
Show Reclassification Out Of Accumulated Other Comprehensive Income breakouts
Reclassification Out Of Accumulated Other Comprehensive Income -596 -370 -61.1%
Net Income Loss Attributable To Nonredeemable Noncontrolling Interest 206 363 -43.3%
Net Income Loss Attributable To Redeemable Noncontrolling Interest 86 — —
Net Income 392,789 374,541 +4.9%
EPS (Basic) 5.97 5.65 +5.7%
EPS (Diluted) 5.89 5.53 +6.5%
Common Stock Dividends Per Share Declared 1.83 1.72 +6.4%
Revenue 3,777,181 3,582,890 +5.4%
Show Geography breakouts
CN 194,406 155,502 +25.0%
DE 163,913 169,891 -3.5%
ES 195,405 171,779 +13.8%
Europe 1,862,559 1,769,868 +5.2%
FR 513,281 499,795 +2.7%
IT 201,895 180,101 +12.1%
Other Europe 788,065 748,302 +5.3%
Other Foreign Countries 648,786 619,552 +4.7%
US 1,071,430 1,037,968 +3.2%
Research & Development 105.1 96.1 +9.4%
Comprehensive Income 635,892 254,035 +150.3%
Wtd Avg Shares (Basic) 65,740 66,334 -0.9%
Wtd Avg Shares (Diluted) 66,725 67,691 -1.4%
Net Income Loss Available To Common Stockholders Basic 392,789 374,541 +4.9%
Revenue From Contract With Customer Including Assessed Tax 3,777,181 3,582,890 +5.4%
Show Business Segments breakouts
Beauty 1,309,437 1,225,730 +6.8%
Beauty · Asia 119,605 83,725 +42.9%
Beauty · Europe 795,903 745,198 +6.8%
Beauty · Latin America 163,880 155,692 +5.3%
Beauty · North America 230,049 241,115 -4.6%
Closures 730,263 714,008 +2.3%
Closures · Asia 70,588 64,835 +8.9%
Closures · Europe 233,510 218,064 +7.1%
Closures · Latin America 83,773 83,376 +0.5%
Closures · North America 342,392 347,733 -1.5%
Pharma 1,737,481 1,643,152 +5.7%
Pharma · Asia 253,722 232,780 +9.0%
Pharma · Europe 833,146 806,606 +3.3%
Pharma · Latin America 48,752 47,124 +3.5%
Pharma · North America 601,861 556,642 +8.1%
Show Geography breakouts
Asia 443,915 381,340 +16.4%
Europe 1,862,559 1,769,868 +5.2%
Latin America 296,405 286,192 +3.6%
North America 1,174,302 1,145,490 +2.5%
Foreign Currency Transaction Gain Loss Before Tax -2.9 -2 -45.0%

Balance Sheet

Balance Sheet
Metric FY 2025 FY 2024 YoY
Current Assets
Cash & Cash Equivalents 402,424 223,844 +79.8%
Short-Term Investments 7,109 2,337 +204.2%
Accounts Notes And Loans Receivable Net Current 803,830 658,057 +22.2%
Inventory 537,845 461,807 +16.5%
Prepaid Expenses & Other Current Assets 142,354 132,338 +7.6%
Total Current Assets 1,893,562 1,478,383 +28.1%
Non-Current Assets
Long Term Investments 131,030 146,269 -10.4%
Goodwill 1,077,898 936,256 +15.1%
Show Business Segments breakouts
Beauty · Operating Segments 370,848 281,286 +31.8%
Beauty · Sommaplast and BTY 71.7 — —
Closures · Operating Segments 168,347 166,736 +1.0%
Pharma · Operating Segments 538,703 488,234 +10.3%
Pharma · Sommaplast and BTY 9.4 — —
Show Business Acquisition breakouts
Sommaplast and BTY 81.1 — —
Intangible Assets 255,339 254,769 +0.2%
Show Finite Lived Intangible Assets By Major Class breakouts
Customer Relationships 154,402 157,730 -2.1%
License agreements and other 22,963 17,344 +32.4%
Patented Technology 57,799 57,273 +0.9%
Patents 15,016 15,990 -6.1%
Trademarks And Trade Names 5,159 6,432 -19.8%
Operating Lease Right-of-Use Assets 65,698 64,213 +2.3%
Other Assets Miscellaneous Noncurrent 152,713 105,238 +45.1%
Other Non-Current Assets 1,682,678 1,506,745 +11.7%
Total Assets 5,252,719 4,432,278 +18.5%
Show Business Segments breakouts
Beauty · Operating Segments 1,691,850 1,392,491 +21.5%
Closures · Operating Segments 799,403 746,127 +7.1%
Pharma · Operating Segments 2,283,609 2,057,586 +11.0%
Show Consolidation Items breakouts
Corporate & Other 477,857 236,074 +102.4%
Operating Segments 4,774,862 4,196,204 +13.8%
Property, Plant & Equipment 1,676,479 1,447,150 +15.8%
Show Geography breakouts
CN 165,598 105,613 +56.8%
DE 266,695 229,637 +16.1%
Europe 1,005,413 867,840 +15.9%
FR 590,775 527,570 +12.0%
IT 51,178 44,087 +16.1%
Other Europe 96,765 66,546 +45.4%
Other Foreign Countries 158,589 124,442 +27.4%
US 346,879 349,255 -0.7%
Other Assets
Land 31,503 28,172 +11.8%
Buildings And Improvements Gross 885,936 751,813 +17.8%
Machinery And Equipment Gross 3,658,289 3,143,236 +16.4%
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization 4,575,728 3,923,221 +16.6%
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization -2,899,249 -2,476,071 -17.1%
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization 1,676,479 1,447,150 +15.8%
Current Liabilities
Long Term Debt And Capital Lease Obligations Current 159,584 162,250 -1.6%
Accounts Payable Accrued Liabilities And Derivative Liabilities Current 822,913 729,996 +12.7%
Total Current Liabilities 1,166,444 1,068,281 +9.2%
Deferred Revenue (Current) 74,827 64,425 +16.1%
Non-Current Liabilities
Deferred Tax Liabilities 19,649 14,259 +37.8%
Pension And Other Postretirement Plan Liabilities And Deferred Compensation Liability Noncurrent 67,596 62,210 +8.7%
Operating Lease Liabilities 47,940 49,716 -3.6%
Other Liabilities And Deferred Revenue Noncurrent 99,432 63,822 +55.8%
Deferred Liabilities And Other Liabilities Noncurrent 234,617 190,007 +23.5%
Contract With Customer Liability Noncurrent 49,901 40,551 +23.1%
Other Liabilities
Short Term Borrowings 183,947 176,035 +4.5%
Show Short Term Debt Type breakouts
Line Of Credit 152,633 176,035 -13.3%
Short-term obligations 1.50% to 3.00% 31,314 — —
Long Term Debt And Capital Lease Obligations 1,139,433 688,066 +65.6%
Minority Interest 17,885 14,036 +27.4%
Stockholders' Equity
Redeemable Noncontrolling Interest Equity Carrying Amount 26,244 — —
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests 26,244 — —
Common Stock 728 725 +0.4%
Additional Paid In Capital Common Stock 1,165,518 1,125,882 +3.5%
Retained Earnings 2,642,552 2,370,537 +11.5%
Accumulated Other Comprehensive Income -186,382 -429,475 +56.6%
Treasury Stock Common Value -954,320 -595,781 -60.2%
Total Stockholders' Equity 2,668,096 2,471,888 +7.9%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2,685,981 2,485,924 +8.0%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 18,078 5,522 +227.4%
Accumulated Gain Loss Net Cash Flow Hedge Parent -24,569 -8,948 -174.6%
Accumulated Other Comprehensive Income -186,382 -429,475 +56.6%
Accumulated Translation Adjustment -179,891 -426,049 +57.8%
Additional Paid In Capital 1,165,518 1,125,882 +3.5%
Common Stock 728 725 +0.4%
Noncontrolling Interest 17,885 14,036 +27.4%
Retained Earnings 2,642,552 2,370,537 +11.5%
Treasury Stock Common -954,320 -595,781 -60.2%
Total Liabilities & Equity 5,252,719 4,432,278 +18.5%

Cash Flow Statement

Cash Flow Statement
Metric FY 2025 FY 2024 YoY
Operating Activities
Depreciation 242,312 219,667 +10.3%
Adjustment For Amortization 45,051 44,117 +2.1%
Stock-Based Compensation 43,941 47,650 -7.8%
Provision For Doubtful Accounts 1,301 1,016 +28.1%
Gain Loss On Disposition Of Assets1 712 -52 +1469.2%
Equity Securities Fv Ni Gain Loss 483 -1,713 +128.2%
Deferred Income Taxes -11,689 -21,406 +45.4%
Employee Benefits And Share Based Compensation 12,554 12,049 +4.2%
Income Loss From Equity Method Investments Net Of Dividends Or Distributions -7,393 -87 -8397.7%
Asset Impairment Charges 2,197 254 +765.0%
Increase Decrease In Accounts And Other Receivables -73,888 -18,079 -308.7%
Change in Inventory -10,646 21,901 -148.6%
Change in Prepaid & Other Assets 4,956 -2,368 +309.3%
Increase Decrease In Accounts Payable And Accrued Liabilities -18,274 -23,705 +22.9%
Increase Decrease In Accrued Income Taxes Payable -9,073 4,064 -323.3%
Increase Decrease In Pension And Postretirement Obligations -6,477 -14,259 +54.6%
Increase Decrease In Retirement And Deferred Compensation Plan Assets -12,582 — —
Increase Decrease In Other Operating Capital Net 535 186 +187.6%
Net Cash from Operations 569,999 643,413 -11.4%
Depreciation & Amortization 287,363 263,784 +8.9%
Show Business Segments breakouts
Beauty · Operating Segments 91,066 82,931 +9.8%
Closures · Operating Segments 56,716 57,326 -1.1%
Pharma · Operating Segments 136,111 120,429 +13.0%
Show Consolidation Items breakouts
Corporate & Other 3,470 3,098 +12.0%
Operating Segments 283,893 260,686 +8.9%
Investing Activities
Capital Expenditures -270,419 -276,481 +2.2%
Proceeds From Government Grants 3,308 — —
Proceeds From Sale Of Property Plant And Equipment 3,547 1,506 +135.5%
Payments For Proceeds From Short Term Investments 3,369 -2,242 +250.3%
Payments To Acquire Businesses Net Of Cash Acquired -60,204 — —
Payments To Acquire Intangible Assets -5,020 -17,709 +71.7%
Show Business Acquisition breakouts
Series Of Individually Immaterial Business Acquisitions -31.2 — —
Series Of Individually Immaterial Business Acquisitions · Customer Relationships -17.4 — —
Series Of Individually Immaterial Business Acquisitions · Other Intangible Assets -6.6 — —
Series Of Individually Immaterial Business Acquisitions · Patented Technology -7.2 — —
Payments To Acquire Equity Securities Fv Ni -8,664 -99,055 +91.3%
Proceeds From Sale Of Equity Securities Fv Ni 2,401 — —
Increase Decrease In Notes Receivables 256 -2,740 +109.3%
Net Cash from Investing -331,426 -396,721 +16.5%
Financing Activities
Proceeds From Notes Payable 31,015 22,302 +39.1%
Repayments Of Notes Payable -28,218 -23,344 -20.9%
Proceeds From Repayments Of Lines Of Credit -42,380 108,848 -138.9%
Proceeds From Issuance Of Long Term Debt 600,206 168,581 +256.0%
Repayments Of Long Term Debt -166,562 -373,847 +55.4%
Payments Of Dividends Common Stock -120,784 -114,055 -5.9%
Debt Issuance Costs -5,424 — —
Proceeds From Stock Options Exercised 18,891 54,809 -65.5%
Share Repurchases -365,005 -68,638 -431.8%
Proceeds From Minority Shareholders 790 — —
Net Cash from Financing -77,471 -225,344 +65.6%
Supplemental
Interest Paid 49,972 43,520 +14.8%
Income Taxes Paid 179,351 89.4 +200516.3%
Show Income Tax Authority breakouts
Domestic Country · Transferable, Non-Refundable U.S. Energy Credits 17.5 — —
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 19,403 -21,147 +191.8%
Net Change in Cash 180,505 201 +89703.5%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 404,849 224,344 +80.5%
Restricted Cash And Cash Equivalents At Carrying Value 606 500 +21.2%
Restricted Cash And Cash Equivalents Noncurrent 1,819 — —

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key